Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study.
Masana L, Zambon A, Schmitt CP, Taylan C, Driemeyer J, Cohen H, Buonuomo PS, Alashwal A, Al-Dubayee M, Kholaif N, Diaz-Diaz JL, Maatouk F, Martinez-Hervas S, Mangal B, Löwe S, Cunningham T. Masana L, et al. Among authors: taylan c. Lancet Diabetes Endocrinol. 2024 Dec;12(12):880-889. doi: 10.1016/S2213-8587(24)00233-X. Epub 2024 Oct 16. Lancet Diabetes Endocrinol. 2024. PMID: 39426393 Clinical Trial.
Single-center outcome analysis of 46 fetuses with megacystis after intrauterine vesico-amniotic shunting with the Somatex®intrauterine shunt.
Gottschalk I, Berg C, Menzel T, Abel JS, Kribs A, Dübbers M, Kohaut J, Weber LT, Taylan C, Habbig S, Liebau MC, Boemers TM, Weber EC. Gottschalk I, et al. Among authors: taylan c. Arch Gynecol Obstet. 2024 Jan;309(1):145-158. doi: 10.1007/s00404-022-06905-6. Epub 2023 Jan 5. Arch Gynecol Obstet. 2024. PMID: 36604332 Free PMC article.
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.
Klaus G, Taylan C, Büscher R, Schmitt CP, Pape L, Oh J, Driemeyer J, Galiano M, König J, Schürfeld C, Spitthöver R, Schaefer JR, Weber LT, Heibges A, Klingel R. Klaus G, et al. Among authors: taylan c. Pediatr Nephrol. 2018 Jul;33(7):1199-1208. doi: 10.1007/s00467-018-3906-6. Epub 2018 Mar 3. Pediatr Nephrol. 2018. PMID: 29502162
Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry.
Luirink IK, Hutten BA, Greber-Platzer S, Kolovou GD, Dann EJ, de Ferranti SD, Taylan C, Bruckert E, Saheb S, Oh J, Driemeyer J, Farnier M, Pape L, Schmitt CP, Novoa FJ, Maeser M, Masana L, Shahrani A, Wiegman A, Groothoff JW. Luirink IK, et al. Among authors: taylan c. Atherosclerosis. 2020 Apr;299:24-31. doi: 10.1016/j.atherosclerosis.2020.01.031. Epub 2020 Feb 18. Atherosclerosis. 2020. PMID: 32199148
Phase 1, single-dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of etelcalcetide in pediatric patients with secondary hyperparathyroidism receiving hemodialysis.
Sohn W, Salusky IB, Schmitt CP, Taylan C, Walle JV, Ngang J, Yan L, Kroenke M, Warady BA. Sohn W, et al. Among authors: taylan c. Pediatr Nephrol. 2021 Jan;36(1):133-142. doi: 10.1007/s00467-020-04599-z. Epub 2020 Jul 9. Pediatr Nephrol. 2021. PMID: 32647975 Clinical Trial.
Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis.
Taylan C, Driemeyer J, Schmitt CP, Pape L, Büscher R, Galiano M, König J, Schürfeld C, Spitthöver R, Versen A, Koziolek M, Marsen TA, Stein H, Schaefer JR, Heibges A, Klingel R, Oh J, Weber LT, Klaus G. Taylan C, et al. Am J Cardiol. 2020 Dec 1;136:38-48. doi: 10.1016/j.amjcard.2020.09.015. Epub 2020 Sep 16. Am J Cardiol. 2020. PMID: 32946862
Endurance-oriented training program with children and adolescents on maintenance hemodialysis to enhance dialysis efficacy-DiaSport.
Feldkötter M, Thys S, Adams A, Becker I, Büscher R, Pohl M, Schild R, Pape L, Schmitt CP, Taylan C, Wygoda S, Klaus G, Fehrenbach H, Montoya C, Konrad M, Billing H, Schaar B, Hoppe B. Feldkötter M, et al. Among authors: taylan c. Pediatr Nephrol. 2021 Dec;36(12):3923-3932. doi: 10.1007/s00467-021-05114-8. Epub 2021 Jun 12. Pediatr Nephrol. 2021. PMID: 34117528 Free PMC article. Clinical Trial.
Safety of Therapeutic Apheresis in Children and Adolescents.
Taylan C, Schaaf A, Dorn C, Schmitt CP, Loos S, Kanzelmeyer N, Pape L, Müller D, Weber LT, Thumfart J. Taylan C, et al. Front Pediatr. 2022 Apr 12;10:850819. doi: 10.3389/fped.2022.850819. eCollection 2022. Front Pediatr. 2022. PMID: 35498796 Free PMC article.
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPN.
Reijman MD, Kusters DM, Groothoff JW, Arbeiter K, Dann EJ, de Boer LM, de Ferranti SD, Gallo A, Greber-Platzer S, Hartz J, Hudgins LC, Ibarretxe D, Kayikcioglu M, Klingel R, Kolovou GD, Oh J, Planken RN, Stefanutti C, Taylan C, Wiegman A, Schmitt CP. Reijman MD, et al. Among authors: taylan c. medRxiv [Preprint]. 2023 Nov 15:2023.11.14.23298547. doi: 10.1101/2023.11.14.23298547. medRxiv. 2023. Update in: Atherosclerosis. 2024 May;392:117525. doi: 10.1016/j.atherosclerosis.2024.117525 PMID: 38014132 Free PMC article. Updated. Preprint.
34 results